Journal of Postgraduate Medicine, Education and Research

Register      Login

VOLUME 55 , ISSUE 3 ( July-September, 2021 ) > List of Articles


Tocilizumab Magic in Octogenarian Patient of COVID-19 ARDS

Neeraj Singla, Aman Sharma, Deba P Dhibar

Keywords : Acute respiratory distress syndrome, Coronavirus, Interleukin 6

Citation Information :

DOI: 10.5005/jp-journals-10028-1442

License: CC BY-NC 4.0

Published Online: 00-09-2021

Copyright Statement:  Copyright © 2021; The Author(s).


  1. Wiersinga WJ, Rhoades A, Cheng A, et al. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID19): a review. JAMA 2020;324(8):782–793. DOI: 10.1001/ jama.2020.12839.
  2. Fu B, Xu X, Wei H. Why tocilizumab could be an effective treatment for severe COVID-19? J Transl Med 2020;18(1):164. DOI: 10.1186/s12967-020-02339-3.
  3. Tleyjeh IM, Kashour Z, Damlaj M, et al. Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis. Clin Microbiol Infect 2021;27(2):215–227. DOI: 10.1016/j.cmi.2020.10.036.
  4. Salvati L, Occhipinti M, Gori L, et al. Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab. Immunol Lett 2020;228:122–128. DOI: 10.1016/j.imlet.2020.10.009.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.